1-3 of 3
Patrick Mouret
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Venous Thromboembolism (VTE) Prevention with Semuloparin in Cancer Patients Initiating Chemotherapy: Benefit-Risk Assessment by VTE Risk in SAVE-ONCO

Daniel George, Giancarlo Agnelli, William Fisher, Ajay Kakkar, Michael R Lassen, Patrick Mismetti, Patrick Mouret, Francesca Lawson, Alexander G.G. Turpie
Journal: Blood
Blood (2011) 118 (21): 206.
https://doi.org/10.1182/blood.V118.21.206.206
Published: 2011
Journal Articles

The Ultra-Low-Molecular-Weight Heparin Semuloparin for Prevention of Venous Thromboembolism In Patients Undergoing Major Abdominal Surgery

Ajay K. Kakkar, MBBS, PhD, Giancarlo Agnelli, William D. Fisher, MD, Daniel George, Patrick Mouret, Michael R. Lassen, MD, Patrick Mismetti, Judith Murphy, Alexander G.G. Turpie
Journal: Blood
Blood (2010) 116 (21): 188.
https://doi.org/10.1182/blood.V116.21.188.188
Published: 2010
Journal Articles

Extended Thromboprophylaxis with Rivaroxaban Compared with Short-Term Thromboprophylaxis with Enoxaparin after Total Hip Arthroplasty: The RECORD2 Trial.

Ajay K. Kakkar, MD, PhD, Benjamin Brenner, MD, Ola E. Dahl, MD, PhD, Bengt I. Eriksson, MD, PhD, Patrick Mouret, MD, Jim Muntz, MD, Tiemo J. Bandel, MD, Frank Misselwitz, MD, PhD, Sylvia Haas, MD
Journal: Blood
Blood (2007) 110 (11): 307.
https://doi.org/10.1182/blood.V110.11.307.307
Published: 2007